aluates Reports

$ 0.0

Automative

Global Biopharmaceutical and Vaccines Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-28K10314

Global and United States Biopharmaceutical and Vaccines Market Report Forecast 2022 2028

BUY CHAPTERS

Global Biopharmaceutical and Vaccines Market Research Report 2025

Code: QYRE-Auto-28K10314

Report

September 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Pfizer Inc

Sanofi

Roche

Abbott

Biogen Idec

Regeneron Pharmaceuticals

Alexion Pharmaceuticals

Johnson and Johnson

GlaxoSmithKline PLC

Merck

Lonza

Boehringer Ingelheim

Rentschler

Biopharmaceutical and Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical and Vaccines Market

The global market for Biopharmaceutical and Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccines.

The Biopharmaceutical and Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical and Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical and Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biopharmaceutical and Vaccines Market Report

Report Metric	Details
Report Name	Biopharmaceutical and Vaccines Market
CAGR	5%
Segment by Type	Biopharmaceutical Vaccine Production
Segment by Application	Pharmaceuticals Industry Clinical Diagnosis Scientific Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Pfizer, Sanofi, Roche, Abbott, Biogen Idec, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson, GlaxoSmithKline, Merck, Lonza, Boehringer Ingelheim, Rentschler
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biopharmaceutical and Vaccines Market report?

Ans: The main players in the Biopharmaceutical and Vaccines Market are Novartis, Pfizer, Sanofi, Roche, Abbott, Biogen Idec, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson, GlaxoSmithKline, Merck, Lonza, Boehringer Ingelheim, Rentschler

What are the Application segmentation covered in the Biopharmaceutical and Vaccines Market report?

Ans: The Applications covered in the Biopharmaceutical and Vaccines Market report are Pharmaceuticals Industry, Clinical Diagnosis, Scientific Research, Others

What are the Type segmentation covered in the Biopharmaceutical and Vaccines Market report?

Ans: The Types covered in the Biopharmaceutical and Vaccines Market report are Biopharmaceutical, Vaccine Production

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Biopharmaceutical

1.2.3 Vaccine Production

1.3 Market by Application

1.3.1 Global Biopharmaceutical and Vaccines Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceuticals Industry

1.3.3 Clinical Diagnosis

1.3.4 Scientific Research

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical and Vaccines Market Perspective (2020-2031)

2.2 Global Biopharmaceutical and Vaccines Growth Trends by Region

2.2.1 Global Biopharmaceutical and Vaccines Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biopharmaceutical and Vaccines Historic Market Size by Region (2020-2025)

2.2.3 Biopharmaceutical and Vaccines Forecasted Market Size by Region (2026-2031)

2.3 Biopharmaceutical and Vaccines Market Dynamics

2.3.1 Biopharmaceutical and Vaccines Industry Trends

2.3.2 Biopharmaceutical and Vaccines Market Drivers

2.3.3 Biopharmaceutical and Vaccines Market Challenges

2.3.4 Biopharmaceutical and Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical and Vaccines Players by Revenue

3.1.1 Global Top Biopharmaceutical and Vaccines Players by Revenue (2020-2025)

3.1.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Players (2020-2025)

3.2 Global Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biopharmaceutical and Vaccines Revenue

3.4 Global Biopharmaceutical and Vaccines Market Concentration Ratio

3.4.1 Global Biopharmaceutical and Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccines Revenue in 2024

3.5 Global Key Players of Biopharmaceutical and Vaccines Head office and Area Served

3.6 Global Key Players of Biopharmaceutical and Vaccines, Product and Application

3.7 Global Key Players of Biopharmaceutical and Vaccines, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical and Vaccines Breakdown Data by Type

4.1 Global Biopharmaceutical and Vaccines Historic Market Size by Type (2020-2025)

4.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2026-2031)

5 Biopharmaceutical and Vaccines Breakdown Data by Application

5.1 Global Biopharmaceutical and Vaccines Historic Market Size by Application (2020-2025)

5.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biopharmaceutical and Vaccines Market Size (2020-2031)

6.2 North America Biopharmaceutical and Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biopharmaceutical and Vaccines Market Size by Country (2020-2025)

6.4 North America Biopharmaceutical and Vaccines Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical and Vaccines Market Size (2020-2031)

7.2 Europe Biopharmaceutical and Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biopharmaceutical and Vaccines Market Size by Country (2020-2025)

7.4 Europe Biopharmaceutical and Vaccines Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical and Vaccines Market Size (2020-2031)

8.2 Asia-Pacific Biopharmaceutical and Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2020-2025)

8.4 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical and Vaccines Market Size (2020-2031)

9.2 Latin America Biopharmaceutical and Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biopharmaceutical and Vaccines Market Size by Country (2020-2025)

9.4 Latin America Biopharmaceutical and Vaccines Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical and Vaccines Market Size (2020-2031)

10.2 Middle East & Africa Biopharmaceutical and Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2020-2025)

10.4 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Biopharmaceutical and Vaccines Introduction

11.1.4 Novartis Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Biopharmaceutical and Vaccines Introduction

11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Biopharmaceutical and Vaccines Introduction

11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Biopharmaceutical and Vaccines Introduction

11.4.4 Roche Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.4.5 Roche Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Biopharmaceutical and Vaccines Introduction

11.5.4 Abbott Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.5.5 Abbott Recent Development

11.6 Biogen Idec

11.6.1 Biogen Idec Company Details

11.6.2 Biogen Idec Business Overview

11.6.3 Biogen Idec Biopharmaceutical and Vaccines Introduction

11.6.4 Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.6.5 Biogen Idec Recent Development

11.7 Regeneron Pharmaceuticals

11.7.1 Regeneron Pharmaceuticals Company Details

11.7.2 Regeneron Pharmaceuticals Business Overview

11.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Introduction

11.7.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.7.5 Regeneron Pharmaceuticals Recent Development

11.8 Alexion Pharmaceuticals

11.8.1 Alexion Pharmaceuticals Company Details

11.8.2 Alexion Pharmaceuticals Business Overview

11.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Introduction

11.8.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.8.5 Alexion Pharmaceuticals Recent Development

11.9 Johnson and Johnson

11.9.1 Johnson and Johnson Company Details

11.9.2 Johnson and Johnson Business Overview

11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Introduction

11.9.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.9.5 Johnson and Johnson Recent Development

11.10 GlaxoSmithKline

11.10.1 GlaxoSmithKline Company Details

11.10.2 GlaxoSmithKline Business Overview

11.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Introduction

11.10.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.10.5 GlaxoSmithKline Recent Development

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Biopharmaceutical and Vaccines Introduction

11.11.4 Merck Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.11.5 Merck Recent Development

11.12 Lonza

11.12.1 Lonza Company Details

11.12.2 Lonza Business Overview

11.12.3 Lonza Biopharmaceutical and Vaccines Introduction

11.12.4 Lonza Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.12.5 Lonza Recent Development

11.13 Boehringer Ingelheim

11.13.1 Boehringer Ingelheim Company Details

11.13.2 Boehringer Ingelheim Business Overview

11.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Introduction

11.13.4 Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.13.5 Boehringer Ingelheim Recent Development

11.14 Rentschler

11.14.1 Rentschler Company Details

11.14.2 Rentschler Business Overview

11.14.3 Rentschler Biopharmaceutical and Vaccines Introduction

11.14.4 Rentschler Revenue in Biopharmaceutical and Vaccines Business (2020-2025)

11.14.5 Rentschler Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Pfizer Inc

Sanofi

Roche

Abbott

Biogen Idec

Regeneron Pharmaceuticals

Alexion Pharmaceuticals

Johnson and Johnson

GlaxoSmithKline PLC

Merck

Lonza

Boehringer Ingelheim

Rentschler

List of Tables

Table 1. Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Biopharmaceutical

Table 3. Key Players of Vaccine Production

Table 4. Global Biopharmaceutical and Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Biopharmaceutical and Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Biopharmaceutical and Vaccines Market Share by Region (2020-2025)

Table 8. Global Biopharmaceutical and Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Biopharmaceutical and Vaccines Market Share by Region (2026-2031)

Table 10. Biopharmaceutical and Vaccines Market Trends

Table 11. Biopharmaceutical and Vaccines Market Drivers

Table 12. Biopharmaceutical and Vaccines Market Challenges

Table 13. Biopharmaceutical and Vaccines Market Restraints

Table 14. Global Biopharmaceutical and Vaccines Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Biopharmaceutical and Vaccines Market Share by Players (2020-2025)

Table 16. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccines as of 2024)

Table 17. Ranking of Global Top Biopharmaceutical and Vaccines Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccines Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Biopharmaceutical and Vaccines, Headquarters and Area Served

Table 20. Global Key Players of Biopharmaceutical and Vaccines, Product and Application

Table 21. Global Key Players of Biopharmaceutical and Vaccines, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Biopharmaceutical and Vaccines Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2020-2025)

Table 25. Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2026-2031)

Table 27. Global Biopharmaceutical and Vaccines Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2020-2025)

Table 29. Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2026-2031)

Table 31. North America Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Biopharmaceutical and Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Biopharmaceutical and Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Biopharmaceutical and Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Biopharmaceutical and Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Biopharmaceutical and Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novartis Company Details

Table 47. Novartis Business Overview

Table 48. Novartis Biopharmaceutical and Vaccines Product

Table 49. Novartis Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 50. Novartis Recent Development

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Biopharmaceutical and Vaccines Product

Table 54. Pfizer Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Sanofi Company Details

Table 57. Sanofi Business Overview

Table 58. Sanofi Biopharmaceutical and Vaccines Product

Table 59. Sanofi Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 60. Sanofi Recent Development

Table 61. Roche Company Details

Table 62. Roche Business Overview

Table 63. Roche Biopharmaceutical and Vaccines Product

Table 64. Roche Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 65. Roche Recent Development

Table 66. Abbott Company Details

Table 67. Abbott Business Overview

Table 68. Abbott Biopharmaceutical and Vaccines Product

Table 69. Abbott Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 70. Abbott Recent Development

Table 71. Biogen Idec Company Details

Table 72. Biogen Idec Business Overview

Table 73. Biogen Idec Biopharmaceutical and Vaccines Product

Table 74. Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 75. Biogen Idec Recent Development

Table 76. Regeneron Pharmaceuticals Company Details

Table 77. Regeneron Pharmaceuticals Business Overview

Table 78. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product

Table 79. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 80. Regeneron Pharmaceuticals Recent Development

Table 81. Alexion Pharmaceuticals Company Details

Table 82. Alexion Pharmaceuticals Business Overview

Table 83. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product

Table 84. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 85. Alexion Pharmaceuticals Recent Development

Table 86. Johnson and Johnson Company Details

Table 87. Johnson and Johnson Business Overview

Table 88. Johnson and Johnson Biopharmaceutical and Vaccines Product

Table 89. Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 90. Johnson and Johnson Recent Development

Table 91. GlaxoSmithKline Company Details

Table 92. GlaxoSmithKline Business Overview

Table 93. GlaxoSmithKline Biopharmaceutical and Vaccines Product

Table 94. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 95. GlaxoSmithKline Recent Development

Table 96. Merck Company Details

Table 97. Merck Business Overview

Table 98. Merck Biopharmaceutical and Vaccines Product

Table 99. Merck Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 100. Merck Recent Development

Table 101. Lonza Company Details

Table 102. Lonza Business Overview

Table 103. Lonza Biopharmaceutical and Vaccines Product

Table 104. Lonza Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 105. Lonza Recent Development

Table 106. Boehringer Ingelheim Company Details

Table 107. Boehringer Ingelheim Business Overview

Table 108. Boehringer Ingelheim Biopharmaceutical and Vaccines Product

Table 109. Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 110. Boehringer Ingelheim Recent Development

Table 111. Rentschler Company Details

Table 112. Rentschler Business Overview

Table 113. Rentschler Biopharmaceutical and Vaccines Product

Table 114. Rentschler Revenue in Biopharmaceutical and Vaccines Business (2020-2025) & (US$ Million)

Table 115. Rentschler Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Biopharmaceutical and Vaccines Picture

Figure 2. Global Biopharmaceutical and Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biopharmaceutical and Vaccines Market Share by Type: 2024 VS 2031

Figure 4. Biopharmaceutical Features

Figure 5. Vaccine Production Features

Figure 6. Global Biopharmaceutical and Vaccines Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Biopharmaceutical and Vaccines Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceuticals Industry Case Studies

Figure 9. Clinical Diagnosis Case Studies

Figure 10. Scientific Research Case Studies

Figure 11. Others Case Studies

Figure 12. Biopharmaceutical and Vaccines Report Years Considered

Figure 13. Global Biopharmaceutical and Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Biopharmaceutical and Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Biopharmaceutical and Vaccines Market Share by Region: 2024 VS 2031

Figure 16. Global Biopharmaceutical and Vaccines Market Share by Players in 2024

Figure 17. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccines as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccines Revenue in 2024

Figure 19. North America Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Biopharmaceutical and Vaccines Market Share by Country (2020-2031)

Figure 21. United States Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Biopharmaceutical and Vaccines Market Share by Country (2020-2031)

Figure 25. Germany Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Biopharmaceutical and Vaccines Market Share by Region (2020-2031)

Figure 33. China Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Biopharmaceutical and Vaccines Market Share by Country (2020-2031)

Figure 41. Mexico Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Biopharmaceutical and Vaccines Market Share by Country (2020-2031)

Figure 45. Turkey Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Biopharmaceutical and Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 50. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 51. Roche Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 53. Biogen Idec Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 54. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 55. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 56. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 57. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 58. Merck Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 59. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 60. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 61. Rentschler Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Biopharmaceutical Drug Delivery Technologies Market Research Report 2024

Global Biopharmaceutical Stock Solution Market Research Report 2024

Global Biopharmaceutical Drug Delivery Devices Market Research Report 2024

Global Livestock Vaccine Market Research Report 2025

Biopharmaceutical Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceuticals Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic BCG Vaccines Market Insights Forecast to 2030

Global Attenuated Vaccine Market Research Report 2025

Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biopharmaceutical Excipients Market Insights Forecast to 2030

Global Biopharmaceutical CRO Market Research Report 2024

Prostate Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Excipient Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Combinations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Vaccine Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions